ArticleFrontiers in oncology2022

High-dose cytarabine monotherapy is superior to standard-dose cytarabine- based multiagent sequential treatment cycle for consolidation treatment in adult (14-59 years) AML patients according to European Leukemia Net 2022 risk stratification.

Xiaoyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.